Vivoryon

Vivoryon:
Develops small molecule medicines that modulate the activity and stability of pathologically altered proteins. Lead candidate varoglutamstat, currently in VIVIAD EU Ph2b and VIVA-MIND US Ph2a/2b studies in Alzheimer’s disease (AD), targets all three major hallmarks of AD (Abeta pathology, tau pathology, neuroinflammation) upstream of other approaches. Varoglutamstat Ph2a trial showed significant improvement in cognition parameter within 3 months and Lilly’s mAb donanemab Ph2 data provided further validation of the N3pE amyloid target.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Phase l or ll
Disease Space
Central Nervous System
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Europe, Public
Market Cap
100MM - 500MM
Therapeutic Modalities
Small Molecule
Website:
Profiles:
Address:
Weinbergweg 22
Halle/Saale, 06120
Germany
Halle/Saale, 06120
Germany
More info:
My account:
Company Participants at Vivoryon KOL Breakfast and Networking Event at AAIC 2022
- Ulrich Dauer, CEO
Top 10 Holders of Vivoryon Therapeutics N.V.
Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
---|---|---|---|---|---|
GS&P Kapitalanlagegesellschaft SA | 5.52 | 1,330,000 | 0.00 | Stakes | 5/26/23 |
Mackenzie Financial Corp. | 4.37 | 1,053,206 | 0.00 | Stakes | 12/31/22 |
Mackenzie Investments Asia Ltd. | 3.62 | 797,264 | 0.00 | Funds | 9/30/22 |
Lupus alpha Asset Management AG | 3.39 | 817,500 | 0.00 | Stakes | 5/26/23 |
Norges Bank Investment Management | 1.73 | 415,999 | 0.00 | Funds | 12/31/22 |
Mackenzie Investments Europe Ltd. | 1.24 | 274,132 | 0.00 | Funds | 9/30/22 |
Matejka & Partner Asset Management GmbH | 1.05 | 253,760 | 0.00 | Funds | 5/23/23 |
Kairos Partners SGR SpA | 0.83 | 200,000 | 0.00 | Funds | 2/28/23 |
Lemanik SA | 0.74 | 178,412 | 0.00 | Funds | 4/28/23 |
GVC Gaesco Gestión SGIIC SA | 0.25 | 54,999 | 0.00 | Funds | 9/30/22 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.